A new test allows physicians to measure the effects of gene silencing therapy in Huntington's disease and will support the first human clinical trial of a drug that targets the genetic cause of the disease.
New test measures effectiveness of treatments for Huntington's disease
Science Daily - 7 Aug 2015 17:07
A new test allows physicians to measure the effects of gene silencing therapy in Huntington's disease and will support the first human clinical trial of a drug that targets the genetic cause of the disease.
Share this Article
Recommended